Alzheimer's Disease Fact Sheet

Anyone with Alzheimer's disease or MCI, and healthy volunteers with or without a family history of Alzheimer's disease, can participate in clinical trials and research. Participants in Alzheimer's disease clinical trials will help scientists understand the brain's changes in healthy aging and Alzheimer's disease. Currently, at least 70,000 volunteers are required to participate in over 150 active clinical trials and studies testing methods to understand, diagnose, treat and prevent Alzheimer's disease .

Participation in clinical trials will help fight Alzheimer's disease. The research requires participants of different ages, sexes, races and ethnic groups to ensure that the results are meaningful to many people

The National Institute of Aging (NIA) of the National Institute of Health (NIH) is leading the federal government's research on Alzheimer's disease. US NAI support Alzheimer's Disease Center conducts extensive research including pathogenesis, diagnosis and treatment of Alzheimer's disease. NIA is also sponsoring the Alzheimer's Disease Cooperative Study (ADCS), a consortium of leading researchers in the United States and Canada, which is conducting clinical trials.

Search ADEAR center clinical trial search for your near exam or register for an email alert regarding the new exam.

Register your registration form (such as Alzheimer's Prevention Registry) or matching service (such as TrialMatch) and invite participation in the exam.

Introduction of Alzheimer's Disease Alzheimer's disease (AD) is the most common cause of dementia in the elderly. Dementia is a disease that destroys the manner in which the brain works. AD affects the mind, memory, and brain parts of the language. Every day, scientists know more about AD, but the cause of this disease is yet to be known and there is no cure. It is estimated that 4 million people suffer from AD in the United States. This disease usually develops after age 65, and the risk of AD increases with age. Young people may also suffer from AD, but they are not so common. Approximately 3% of men and women aged 65 to 74 suffer from AD, and nearly half of those over 85 years suffer from this disease. However, it is important to note that AD is not a normal part of aging. Scientists also discovered other changes in the brains of AD patients. Loss of nerve cells in the brain area is important for memory and other mental abilities. AD starts slowly

Alzheimer's disease is the most common dementia to people over the age of 65. In fact, the Alzheimer's Association published a report on facts and data on Alzheimer's disease in 2018. One of the main findings is that there are about 5.7 million people currently with Alzheimer's disease in the United States. By 2050, this number is expected to reach about 13.8 million Americans (Alzheimer's Association, 2018). The causes of dementia caused by Alzheimer's disease, risk factors and symptoms are somewhat different from other forms of dementia. In the case of AD, this disease first attacks the memory center of the brain.

According to the Centers for Disease Control, Alzheimer's disease is a common cause of dementia, which ranges from 50% to 70% of cases of dementia. Indeed, Alzheimer's disease is a very special form of dementia. Symptoms of Alzheimer's disease include thought disorder, speech disturbance and confusion. Physicians use a variety of screening tests, such as blood tests, mental status assessment, and brain scanning, to identify the cause of dementia. When a person is diagnosed with dementia, they are diagnosed as a series of symptoms. This resembles a person with a sore throat. Their throat hurts, I do not know the cause of this particular symptom. It may be an allergy, a streptococcal infection or a cold. Similarly, when someone suffers from dementia, they will develop symptoms without being told of the cause of these symptoms.